Glioma CpG Island Methylator Phenotype (G-CIMP): Biological and Clinical Implications.

about

Defining Driver DNA Methylation Changes in Human Cancer.The developmental origin of brain tumours: a cellular and molecular framework.Bridging Cancer Biology with the Clinic: Comprehending and Exploiting IDH Gene Mutations in Gliomas

P2860

Q52719825-B7753A28-C57B-44E6-95D9-0749907ACFDF Q55399267-A6247CC8-7F60-45FC-96DC-1DD6BD03AEF5 Q58766030-C49EDBF5-CA85-49A5-BB62-0D4CF1B07D4B

P2860

Glioma CpG Island Methylator Phenotype (G-CIMP): Biological and Clinical Implications.

Item

http://www.wikidata.org/entity/Q47894744

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Glioma CpG Island Methylator Phenotype (G-CIMP): Biological and Clinical Implications.

@en

Glioma CpG Island Methylator Phenotype

@nl

type

Item

label

Glioma CpG Island Methylator Phenotype (G-CIMP): Biological and Clinical Implications.

@en

Glioma CpG Island Methylator Phenotype

@nl

prefLabel

Glioma CpG Island Methylator Phenotype (G-CIMP): Biological and Clinical Implications.

@en

Glioma CpG Island Methylator Phenotype

@nl

P1476

Glioma CpG Island Methylator Phenotype (G-CIMP): Biological and Clinical Implications.

@en

P2093

Ana Valeria B Castro

http://www.w3.org/2001/XMLSchema#string

Camila F de Souza

http://www.w3.org/2001/XMLSchema#string

Houtan Noushmehr

http://www.w3.org/2001/XMLSchema#string

James Snyder

http://www.w3.org/2001/XMLSchema#string

Maritza Q S Mosella

http://www.w3.org/2001/XMLSchema#string

Steven N Kalkanis

http://www.w3.org/2001/XMLSchema#string

Tathiane M Malta

http://www.w3.org/2001/XMLSchema#string

Thais S Sabedot

http://www.w3.org/2001/XMLSchema#string

Tiago C Silva

http://www.w3.org/2001/XMLSchema#string

P2860

EUKARYOTIC CYTOSINE METHYLTRANSFERASES

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

IDH1 and IDH2 mutations in gliomas

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases

An integrated genomic analysis of human glioblastoma multiforme

IDH1 and IDH2 mutations in gliomas

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

CpG island methylator phenotype in colorectal cancer

P31

scholarly article

P356

10.1093/NEUONC/NOX183

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29036500

http://www.w3.org/2001/XMLSchema#string

P932

5892155

http://www.w3.org/2001/XMLSchema#string

Glioma CpG Island Methylator Phenotype (G-CIMP): Biological and Clinical Implications.

about

P2860

P2860

Glioma CpG Island Methylator Phenotype (G-CIMP): Biological and Clinical Implications.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P577

P698

P932